{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T18:40:13Z","timestamp":1795027213474,"version":"4.10.2"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,2,4]],"date-time":"2024-02-04T00:00:00Z","timestamp":1707004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,2,4]],"date-time":"2024-02-04T00:00:00Z","timestamp":1707004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["R01EY029913-0321"],"award-info":[{"award-number":["R01EY029913-0321"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["R01EY029913"],"award-info":[{"award-number":["R01EY029913"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Diabetic retinopathy (DR) affects about 200 million people worldwide, causing leakage of blood components into retinal tissues, leading to activation of microglia, the resident phagocytes of the retina, promoting neuronal and vascular damage. The microglial receptor, CX3CR1, binds to fractalkine (FKN), an anti-inflammatory chemokine that is expressed on neuronal membranes (mFKN), and undergoes constitutive cleavage to release a soluble domain (sFKN). Deficiencies in CX3CR1 or FKN showed increased microglial activation, inflammation, vascular damage, and neuronal loss in experimental mouse models. To understand the mechanism that regulates microglia function, recombinant adeno-associated viral vectors (rAAV) expressing mFKN or sFKN were delivered to intact retinas prior to diabetes. High-resolution confocal imaging and mRNA-seq were used to analyze microglia morphology and markers of expression, neuronal and vascular health, and inflammatory mediators. We confirmed that prophylactic intra-vitreal administration of rAAV expressing sFKN (rAAV\u2013sFKN), but not mFKN (rAAV\u2013mFKN), in FKN\n                    <jats:sup>KO<\/jats:sup>\n                    retinas provided vasculo- and neuro-protection, reduced microgliosis, mitigated inflammation, improved overall optic nerve health by regulating microglia-mediated inflammation, and prevented fibrin(ogen) leakage at 4 weeks and 10 weeks of diabetes induction. Moreover, administration of sFKN improved visual acuity. Our results elucidated a novel intervention via sFKN gene therapy that provides an alternative pathway to implement translational and therapeutic approaches, preventing diabetes-associated blindness.\n                  <\/jats:p>","DOI":"10.1186\/s12974-023-02983-8","type":"journal-article","created":{"date-parts":[[2024,2,4]],"date-time":"2024-02-04T10:02:08Z","timestamp":1707040928000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Fractalkine isoforms differentially regulate microglia-mediated inflammation and enhance visual function in the diabetic retina"],"prefix":"10.1186","volume":"21","author":[{"given":"Derek","family":"Rodriguez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaira A.","family":"Church","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia N.","family":"Pietramale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra M.","family":"Cardona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Difernando","family":"Vanegas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin","family":"Rorex","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micah C.","family":"Leary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel A.","family":"Muzzio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin R.","family":"Nash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Astrid E.","family":"Cardona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,4]]},"reference":[{"issue":"1","key":"2983_CR1","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.3586","volume":"39","author":"K Cai","year":"2023","unstructured":"Cai K, Liu YP, Wang D. Prevalence of diabetic retinopathy in patients with newly diagnosed type 2 diabetes: a systematic review and meta-analysis. Diabetes Metab Res Rev. 2023;39(1): e3586.","journal-title":"Diabetes Metab Res Rev"},{"issue":"5","key":"2983_CR2","doi-asserted-by":"publisher","first-page":"175909141560820","DOI":"10.1177\/1759091415608204","volume":"7","author":"SM Cardona","year":"2015","unstructured":"Cardona SM, Mendiola AS, Yang YC, Adkins SL, Torres V, Cardona AE. Disruption of fractalkine signaling leads to microglial activation and neuronal damage in the diabetic retina. ASN Neuro. 2015;7(5):175909141560820.","journal-title":"ASN Neuro"},{"issue":"1","key":"2983_CR3","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1186\/s12974-022-02659-9","volume":"19","author":"KA Church","year":"2022","unstructured":"Church KA, Rodriguez D, Vanegas D, Gutierrez IL, Cardona SM, Madrigal JLM, Kaur T, Cardona AE. Models of microglia depletion and replenishment elicit protective effects to alleviate vascular and neuronal damage in the diabetic murine retina. J Neuroinflamm. 2022;19(1):300.","journal-title":"J Neuroinflamm"},{"key":"2983_CR4","first-page":"303","volume":"10","author":"AS Mendiola","year":"2016","unstructured":"Mendiola AS, Garza R, Cardona SM, Mythen SA, Lira SA, Akassoglou K, Cardona AE. Fractalkine signaling attenuates perivascular clustering of microglia and fibrinogen leakage during systemic inflammation in mouse models of diabetic retinopathy. Front Cell Neurosci. 2016;10:303.","journal-title":"Front Cell Neurosci"},{"key":"2983_CR5","doi-asserted-by":"publisher","first-page":"175909142211314","DOI":"10.1177\/17590914221131446","volume":"14","author":"B Sarker","year":"2022","unstructured":"Sarker B, Cardona SM, Church KA, Vanegas D, Velazquez P, Rorex C, Rodriguez D, Mendiola AS, Kern TS, Domingo ND, et al. Defibrinogenation ameliorates retinal microgliosis and inflammation in A CX3CR1-independent manner. ASN Neuro. 2022;14:17590914221131446.","journal-title":"ASN Neuro"},{"issue":"2","key":"2983_CR6","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.clnu.2018.03.016","volume":"38","author":"A Camargo","year":"2019","unstructured":"Camargo A, Jimenez-Lucena R, Alcala-Diaz JF, Rangel-Zuniga OA, Garcia-Carpintero S, Lopez-Moreno J, Blanco-Rojo R, Delgado-Lista J, Perez-Martinez P, van Ommen B, et al. Postprandial endotoxemia may influence the development of type 2 diabetes mellitus: from the CORDIOPREV study. Clin Nutr. 2019;38(2):529\u201338.","journal-title":"Clin Nutr"},{"key":"2983_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.594150","volume":"11","author":"S Mohammad","year":"2020","unstructured":"Mohammad S, Thiemermann C. Role of metabolic endotoxemia in systemic inflammation and potential interventions. Front Immunol. 2020;11: 594150.","journal-title":"Front Immunol"},{"issue":"2","key":"2983_CR8","doi-asserted-by":"publisher","first-page":"392","DOI":"10.2337\/dc10-1676","volume":"34","author":"PJ Pussinen","year":"2011","unstructured":"Pussinen PJ, Havulinna AS, Lehto M, Sundvall J, Salomaa V. Endotoxemia is associated with an increased risk of incident diabetes. Diabetes Care. 2011;34(2):392\u20137.","journal-title":"Diabetes Care"},{"issue":"6","key":"2983_CR9","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.3390\/ijms19061816","volume":"19","author":"W Wang","year":"2018","unstructured":"Wang W, Lo ACY. Diabetic retinopathy: pathophysiology and treatments. Int J Mol Sci. 2018;19(6):1816.","journal-title":"Int J Mol Sci"},{"issue":"9735","key":"2983_CR10","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/S0140-6736(09)62124-3","volume":"376","author":"N Cheung","year":"2010","unstructured":"Cheung N, Mitchell P, Wong TY. Diabetic retinopathy. Lancet. 2010;376(9735):124\u201336.","journal-title":"Lancet"},{"issue":"8","key":"2983_CR11","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1172\/JCI16790","volume":"111","author":"DH McDermott","year":"2003","unstructured":"McDermott DH, Fong AM, Yang Q, Sechler JM, Cupples LA, Merrell MN, Wilson PW, D\u2019Agostino RB, O\u2019Donnell CJ, Patel DD, et al. Chemokine receptor mutant CX3CR1-M280 has impaired adhesive function and correlates with protection from cardiovascular disease in humans. J Clin Invest. 2003;111(8):1241\u201350.","journal-title":"J Clin Invest"},{"issue":"7","key":"2983_CR12","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1182\/blood.V97.7.1925","volume":"97","author":"D Moatti","year":"2001","unstructured":"Moatti D, Faure S, Fumeron F, Amara Mel W, Seknadji P, McDermott DH, Debre P, Aumont MC, Murphy PM, de Prost D, et al. Polymorphism in the fractalkine receptor CX3CR1 as a genetic risk factor for coronary artery disease. Blood. 2001;97(7):1925\u20138.","journal-title":"Blood"},{"key":"2983_CR13","doi-asserted-by":"publisher","first-page":"354","DOI":"10.3389\/fncel.2015.00354","volume":"9","author":"S Bardehle","year":"2015","unstructured":"Bardehle S, Rafalski VA, Akassoglou K. Breaking boundaries-coagulation and fibrinolysis at the neurovascular interface. Front Cell Neurosci. 2015;9:354.","journal-title":"Front Cell Neurosci"},{"key":"2983_CR14","doi-asserted-by":"publisher","first-page":"591","DOI":"10.3389\/fendo.2020.00591","volume":"11","author":"F Gui","year":"2020","unstructured":"Gui F, You Z, Fu S, Wu H, Zhang Y. Endothelial dysfunction in diabetic retinopathy. Front Endocrinol. 2020;11:591.","journal-title":"Front Endocrinol"},{"issue":"5","key":"2983_CR15","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1124\/mi.10.5.3","volume":"10","author":"BA Jones","year":"2010","unstructured":"Jones BA, Beamer M, Ahmed S. Fractalkine\/CX3CL1: a potential new target for inflammatory diseases. Mol Interv. 2010;10(5):263\u201370.","journal-title":"Mol Interv"},{"issue":"1","key":"2983_CR16","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1161\/01.ATV.0000095360.62479.1F","volume":"24","author":"H Umehara","year":"2004","unstructured":"Umehara H, Bloom ET, Okazaki T, Nagano Y, Yoshie O, Imai T. Fractalkine in vascular biology: from basic research to clinical disease. Arterioscler Thromb Vasc Biol. 2004;24(1):34\u201340.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"41","key":"2983_CR17","doi-asserted-by":"publisher","first-page":"37993","DOI":"10.1074\/jbc.M106434200","volume":"276","author":"KJ Garton","year":"2001","unstructured":"Garton KJ, Gough PJ, Blobel CP, Murphy G, Greaves DR, Dempsey PJ, Raines EW. Tumor necrosis factor-alpha-converting enzyme (ADAM17) mediates the cleavage and shedding of fractalkine (CX3CL1). J Biol Chem. 2001;276(41):37993\u20138001.","journal-title":"J Biol Chem"},{"issue":"4","key":"2983_CR18","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1182\/blood-2002-12-3775","volume":"102","author":"C Hundhausen","year":"2003","unstructured":"Hundhausen C, Misztela D, Berkhout TA, Broadway N, Saftig P, Reiss K, Hartmann D, Fahrenholz F, Postina R, Matthews V, et al. The disintegrin-like metalloproteinase ADAM10 is involved in constitutive cleavage of CX3CL1 (fractalkine) and regulates CX3CL1-mediated cell-cell adhesion. Blood. 2003;102(4):1186\u201395.","journal-title":"Blood"},{"issue":"18","key":"2983_CR19","doi-asserted-by":"publisher","first-page":"10896","DOI":"10.1073\/pnas.95.18.10896","volume":"95","author":"JK Harrison","year":"1998","unstructured":"Harrison JK, Jiang Y, Chen S, Xia Y, Maciejewski D, McNamara RK, Streit WJ, Salafranca MN, Adhikari S, Thompson DA, et al. Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia. Proc Natl Acad Sci U S A. 1998;95(18):10896\u2013901.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"42","key":"2983_CR20","doi-asserted-by":"publisher","first-page":"14592","DOI":"10.1523\/JNEUROSCI.0539-12.2012","volume":"32","author":"JM Morganti","year":"2012","unstructured":"Morganti JM, Nash KR, Grimmig BA, Ranjit S, Small B, Bickford PC, Gemma C. The soluble isoform of CX3CL1 is necessary for neuroprotection in a mouse model of Parkinson\u2019s disease. J Neurosci. 2012;32(42):14592\u2013601.","journal-title":"J Neurosci"},{"issue":"37","key":"2983_CR21","doi-asserted-by":"publisher","first-page":"12538","DOI":"10.1523\/JNEUROSCI.0853-14.2014","volume":"34","author":"S Lee","year":"2014","unstructured":"Lee S, Xu G, Jay TR, Bhatta S, Kim KW, Jung S, Landreth GE, Ransohoff RM, Lamb BT. Opposing effects of membrane-anchored CX3CL1 on amyloid and tau pathologies via the p38 MAPK pathway. J Neurosci. 2014;34(37):12538\u201346.","journal-title":"J Neurosci"},{"issue":"11","key":"2983_CR22","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1007\/s00109-016-1433-0","volume":"94","author":"E Beli","year":"2016","unstructured":"Beli E, Dominguez JM 2nd, Hu P, Thinschmidt JS, Caballero S, Li Calzi S, Luo D, Shanmugam S, Salazar TE, Duan Y, et al. CX3CR1 deficiency accelerates the development of retinopathy in a rodent model of type 1 diabetes. J Mol Med. 2016;94(11):1255\u201365.","journal-title":"J Mol Med"},{"key":"2983_CR23","doi-asserted-by":"publisher","first-page":"1130735","DOI":"10.3389\/fimmu.2023.1130735","volume":"14","author":"KA Church","year":"2023","unstructured":"Church KA, Rodriguez D, Mendiola AS, Vanegas D, Gutierrez IL, Tamayo I, Amadu A, Velazquez P, Cardona SM, Gyoneva S, et al. Pharmacological depletion of microglia alleviates neuronal and vascular damage in the diabetic CX3CR1-WT retina but not in CX3CR1-KO or hCX3CR1(I249\/M280)-expressing retina. Front Immunol. 2023;14:1130735.","journal-title":"Front Immunol"},{"issue":"1","key":"2983_CR24","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s12974-020-01828-y","volume":"17","author":"AN Winter","year":"2020","unstructured":"Winter AN, Subbarayan MS, Grimmig B, Weesner JA, Moss L, Peters M, Weeber E, Nash K, Bickford PC. Two forms of CX3CL1 display differential activity and rescue cognitive deficits in CX3CL1 knockout mice. J Neuroinflamm. 2020;17(1):157.","journal-title":"J Neuroinflamm"},{"issue":"4","key":"2983_CR25","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1002\/(SICI)1098-1136(199612)18:4<269::AID-GLIA2>3.0.CO;2-T","volume":"18","author":"H Fujita","year":"1996","unstructured":"Fujita H, Tanaka J, Toku K, Tateishi N, Suzuki Y, Matsuda S, Sakanaka M, Maeda N. Effects of GM-CSF and ordinary supplements on the ramification of microglia in culture: a morphometrical study. Glia. 1996;18(4):269\u201381.","journal-title":"Glia"},{"key":"2983_CR26","volume":"48","author":"PA Pino","year":"2011","unstructured":"Pino PA, Cardona AE. Isolation of brain and spinal cord mononuclear cells using percoll gradients. J Vis Exp. 2011;48: e2348.","journal-title":"J Vis Exp"},{"issue":"10","key":"2983_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0013693","volume":"5","author":"N Saederup","year":"2010","unstructured":"Saederup N, Cardona AE, Croft K, Mizutani M, Cotleur AC, Tsou CL, Ransohoff RM, Charo IF. Selective chemokine receptor usage by central nervous system myeloid cells in CCR2-red fluorescent protein knock-in mice. PLoS ONE. 2010;5(10): e13693.","journal-title":"PLoS ONE"},{"key":"2983_CR28","doi-asserted-by":"publisher","first-page":"365","DOI":"10.3389\/fncel.2018.00365","volume":"12","author":"SM Cardona","year":"2018","unstructured":"Cardona SM, Kim SV, Church KA, Torres VO, Cleary IA, Mendiola AS, Saville SP, Watowich SS, Parker-Thornburg J, Soto-Ospina A, et al. Role of the fractalkine receptor in CNS autoimmune inflammation: new approach utilizing a mouse model expressing the human CX3CR1(I249\/M280) variant. Front Cell Neurosci. 2018;12:365.","journal-title":"Front Cell Neurosci"},{"issue":"6","key":"2983_CR29","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1177\/09567976211055373","volume":"33","author":"ME Normandin","year":"2022","unstructured":"Normandin ME, Garza MC, Ramos-Alvarez MM, Julian JB, Eresanara T, Punjaala N, Vasquez JH, Lopez MR, Muzzio IA. Navigable space and traversable edges differentially influence reorientation in sighted and blind mice. Psychol Sci. 2022;33(6):925\u201347.","journal-title":"Psychol Sci"},{"issue":"7","key":"2983_CR30","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1038\/nn1715","volume":"9","author":"AE Cardona","year":"2006","unstructured":"Cardona AE, Pioro EP, Sasse ME, Kostenko V, Cardona SM, Dijkstra IM, Huang D, Kidd G, Dombrowski S, Dutta R, et al. Control of microglial neurotoxicity by the fractalkine receptor. Nat Neurosci. 2006;9(7):917\u201324.","journal-title":"Nat Neurosci"},{"issue":"51","key":"2983_CR31","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2112561118","volume":"118","author":"SA Mills","year":"2021","unstructured":"Mills SA, Jobling AI, Dixon MA, Bui BV, Vessey KA, Phipps JA, Greferath U, Venables G, Wong VHY, Wong CHY, et al. Fractalkine-induced microglial vasoregulation occurs within the retina and is altered early in diabetic retinopathy. Proc Natl Acad Sci U S A. 2021;118(51): e2112561118.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"2983_CR32","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1097\/IAE.0b013e31820a67e4","volume":"31","author":"CA McCannel","year":"2011","unstructured":"McCannel CA. Meta-analysis of endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents: causative organisms and possible prevention strategies. Retina. 2011;31(4):654\u201361.","journal-title":"Retina"},{"issue":"8","key":"2983_CR33","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1111\/jdi.13480","volume":"12","author":"KY Lin","year":"2021","unstructured":"Lin KY, Hsih WH, Lin YB, Wen CY, Chang TJ. Update in the epidemiology, risk factors, screening, and treatment of diabetic retinopathy. J Diabetes Investig. 2021;12(8):1322\u20135.","journal-title":"J Diabetes Investig"},{"issue":"6","key":"2983_CR34","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1016\/j.neurobiolaging.2012.12.011","volume":"34","author":"KR Nash","year":"2013","unstructured":"Nash KR, Lee DC, Hunt JB Jr, Morganti JM, Selenica ML, Moran P, Reid P, Brownlow M, Guang-Yu Yang C, Savalia M, et al. Fractalkine overexpression suppresses tau pathology in a mouse model of tauopathy. Neurobiol Aging. 2013;34(6):1540\u20138.","journal-title":"Neurobiol Aging"},{"issue":"1","key":"2983_CR35","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/mt.2014.175","volume":"23","author":"KR Nash","year":"2015","unstructured":"Nash KR, Moran P, Finneran DJ, Hudson C, Robinson J, Morgan D, Bickford PC. Fractalkine over expression suppresses alpha-synuclein-mediated neurodegeneration. Mol Ther. 2015;23(1):17\u201323.","journal-title":"Mol Ther"},{"issue":"1","key":"2983_CR36","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12974-019-1412-9","volume":"16","author":"DJ Finneran","year":"2019","unstructured":"Finneran DJ, Nash KR. Neuroinflammation and fractalkine signaling in Alzheimer\u2019s disease. J Neuroinflamm. 2019;16(1):30.","journal-title":"J Neuroinflamm"},{"key":"2983_CR37","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1742-2094-8-9","volume":"8","author":"MM Pabon","year":"2011","unstructured":"Pabon MM, Bachstetter AD, Hudson CE, Gemma C, Bickford PC. CX3CL1 reduces neurotoxicity and microglial activation in a rat model of Parkinson\u2019s disease. J Neuroinflamm. 2011;8:9.","journal-title":"J Neuroinflamm"},{"issue":"2","key":"2983_CR38","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.ymthe.2020.11.029","volume":"29","author":"AM Maguire","year":"2021","unstructured":"Maguire AM, Bennett J, Aleman EM, Leroy BP, Aleman TS. Clinical perspective: treating RPE65-associated retinal dystrophy. Mol Ther. 2021;29(2):442\u201363.","journal-title":"Mol Ther"},{"issue":"16","key":"2983_CR39","doi-asserted-by":"publisher","first-page":"12672","DOI":"10.3390\/ijms241612672","volume":"24","author":"G Zerbini","year":"2023","unstructured":"Zerbini G, Maestroni S, Vigano I, Mosca A, Paleari R, Gabellini D, Galbiati S, Rama P. Progressive thinning of retinal nerve fiber layer\/ganglion cell layer (RNFL\/GCL) as biomarker and pharmacological target of diabetic retinopathy. Int J Mol Sci. 2023;24(16):12672.","journal-title":"Int J Mol Sci"},{"issue":"19","key":"2983_CR40","doi-asserted-by":"publisher","first-page":"E2655","DOI":"10.1073\/pnas.1522014113","volume":"113","author":"EH Sohn","year":"2016","unstructured":"Sohn EH, van Dijk HW, Jiao C, Kok PH, Jeong W, Demirkaya N, Garmager A, Wit F, Kucukevcilioglu M, van Velthoven ME, et al. Retinal neurodegeneration may precede microvascular changes characteristic of diabetic retinopathy in diabetes mellitus. Proc Natl Acad Sci U S A. 2016;113(19):E2655-2664.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5726","key":"2983_CR41","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1126\/science.1110647","volume":"308","author":"A Nimmerjahn","year":"2005","unstructured":"Nimmerjahn A, Kirchhoff F, Helmchen F. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science. 2005;308(5726):1314\u20138.","journal-title":"Science"},{"issue":"6","key":"2983_CR42","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1038\/nn1472","volume":"8","author":"D Davalos","year":"2005","unstructured":"Davalos D, Grutzendler J, Yang G, Kim JV, Zuo Y, Jung S, Littman DR, Dustin ML, Gan WB. ATP mediates rapid microglial response to local brain injury in vivo. Nat Neurosci. 2005;8(6):752\u20138.","journal-title":"Nat Neurosci"},{"key":"2983_CR43","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/1742-2094-9-27","volume":"9","author":"J Vinet","year":"2012","unstructured":"Vinet J, Weering HR, Heinrich A, Kalin RE, Wegner A, Brouwer N, Heppner FL, Rooijen N, Boddeke HW, Biber K. Neuroprotective function for ramified microglia in hippocampal excitotoxicity. J Neuroinflamm. 2012;9:27.","journal-title":"J Neuroinflamm"},{"issue":"20","key":"2983_CR44","doi-asserted-by":"publisher","first-page":"10140","DOI":"10.1073\/pnas.1901787116","volume":"116","author":"SK Wang","year":"2019","unstructured":"Wang SK, Xue Y, Rana P, Hong CM, Cepko CL. Soluble CX3CL1 gene therapy improves cone survival and function in mouse models of retinitis pigmentosa. Proc Natl Acad Sci U S A. 2019;116(20):10140\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"2983_CR45","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1001\/archophthalmol.2007.65","volume":"126","author":"HY Zeng","year":"2008","unstructured":"Zeng HY, Green WR, Tso MO. Microglial activation in human diabetic retinopathy. Arch Ophthalmol. 2008;126(2):227\u201332.","journal-title":"Arch Ophthalmol"},{"key":"2983_CR46","doi-asserted-by":"publisher","first-page":"402","DOI":"10.3389\/fimmu.2014.00402","volume":"5","author":"SS Bohlson","year":"2014","unstructured":"Bohlson SS, O\u2019Conner SD, Hulsebus HJ, Ho MM, Fraser DA. Complement, c1q, and c1q-related molecules regulate macrophage polarization. Front Immunol. 2014;5:402.","journal-title":"Front Immunol"},{"issue":"1","key":"2983_CR47","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12974-017-0814-9","volume":"14","author":"MI Fonseca","year":"2017","unstructured":"Fonseca MI, Chu SH, Hernandez MX, Fang MJ, Modarresi L, Selvan P, MacGregor GR, Tenner AJ. Cell-specific deletion of C1qa identifies microglia as the dominant source of C1q in mouse brain. J Neuroinflamm. 2017;14(1):48.","journal-title":"J Neuroinflamm"},{"key":"2983_CR48","doi-asserted-by":"publisher","first-page":"1145649","DOI":"10.3389\/fimmu.2023.1145649","volume":"14","author":"W Zhang","year":"2023","unstructured":"Zhang W, Chen Y, Pei H. C1q and central nervous system disorders. Front Immunol. 2023;14:1145649.","journal-title":"Front Immunol"},{"key":"2983_CR49","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.jneuroim.2016.07.014","volume":"298","author":"L Taylor","year":"2016","unstructured":"Taylor L, Arner K, Blom AM, Ghosh F. Complimentary action: C1q increases ganglion cell survival in an in vitro model of retinal degeneration. J Neuroimmunol. 2016;298:117\u201329.","journal-title":"J Neuroimmunol"},{"issue":"8","key":"2983_CR50","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1084\/jem.20182238","volume":"216","author":"Q Fan","year":"2019","unstructured":"Fan Q, Gayen M, Singh N, Gao F, He W, Hu X, Tsai LH, Yan R. The intracellular domain of CX3CL1 regulates adult neurogenesis and Alzheimer\u2019s amyloid pathology. J Exp Med. 2019;216(8):1891\u2013903.","journal-title":"J Exp Med"},{"issue":"5","key":"2983_CR51","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1523\/JNEUROSCI.1333-19.2019","volume":"40","author":"Q Fan","year":"2020","unstructured":"Fan Q, He W, Gayen M, Benoit MR, Luo X, Hu X, Yan R. Activated CX3CL1\/Smad2 signals prevent neuronal loss and alzheimer\u2019s tau pathology-mediated cognitive dysfunction. J Neurosci. 2020;40(5):1133\u201344.","journal-title":"J Neurosci"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-023-02983-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12974-023-02983-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-023-02983-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,4]],"date-time":"2024-02-04T13:03:44Z","timestamp":1707051824000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/s12974-023-02983-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,4]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2983"],"URL":"https:\/\/doi.org\/10.1186\/s12974-023-02983-8","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,4]]},"assertion":[{"value":"24 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal studies were performed in accordance with National Institutes of Health guidelines and approved by UTSA\u2013Institutional Animal Care and Use Committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Dr. Astrid Cardona is an editor for the Journal of Neuroinflammation.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"42"}}